Docetaxel 20mg/0.5ml & 80mg/2ml injection Vial

Name Docetaxel 20mg/0.5ml & 80mg/2ml injection Vial
Description Docetaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions. Docetaxel binds to free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly. This leads to the production of microtubule bundles without normal function and to the stabilization of microtubules, which results in the inhibition of mitosis in cells. Docetaxel's binding to microtubules does not alter the number of protofilaments in the bound microtubules, a feature which differs from most spindle poisons currently in clinical use.
Active Ingredient Docetaxel
Indication Docetaxel in combination therapy is indicated for the following cancer types:
  • Breast cancer
  • Non-small cell lung cancer
  • Prostate cancer
  • Gastric adenocarcinoma
  • Head and neck cancer
Strengths 20mg/0.5ml
Business Partner Vianex
Origin Greece